Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 2,303: | Line 2,303: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2024-08-27T16:42:59Z", | ||
"briefDesignDescription" : "Rivaroxaban, ASA, or both in stable CAD", | "briefDesignDescription" : "Rivaroxaban, ASA, or both in stable CAD", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1709118", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1709118", | ||
Line 9,276: | Line 9,276: | ||
}, | }, | ||
{ | { | ||
"timestamp" : " | "timestamp" : "2024-08-27T16:42:48Z", | ||
"briefDesignDescription" : "Rivaroxaban 2.5mg BID in PAD", | "briefDesignDescription" : "Rivaroxaban 2.5mg BID in PAD", | ||
"fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa2000052", | "fulltexturl" : "https://www.nejm.org/doi/10.1056/NEJMoa2000052", |